Coronavirus | First batch of Sputnik V vaccine to arrive in Kanpur medical college for Phase 2, 3 trials

The first batch of Russia’s Sputnik V vaccine for COVID-19 is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted.

The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy’s Laboratories got approval from the Drugs Controller General of India (DCGI) in this regard, an official said.

Speaking to PTI, college principal R.B. Kamal said the human clinical trials of the vaccine will start from next week.

“As many as 180 volunteers have registered for the trials. Head of the research Saurabh Agarwal will determine the dosage of the vaccine to be administered. One dose will be administered and the condition of volunteers will be monitored to determine whether they need further doses or not,” he said.

Mr. Kamal said the volunteers’ vitals and condition will be checked periodically and the data will be analysed to determine whether the vaccine is a success or not.

He said the effect of the vaccine on the volunteers will be studied for seven months after the same is administered once, twice or thrice within an interval of 21 days.

After observing the effects of the vaccine for a month, authorities will be apprised of the results of the trial and they will then make a decision accordingly.

The Ethics Committee of the college has also given permission for the trails, he said.

The vaccine has to be kept at a temperature of -20 to -70 degrees Celsius.

In September, Dr Reddy’s and the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr Reddy’s upon regulatory approval in India.

On August 11, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against COVID-19 based on the human adenoviral vector platform.

 

Disclaimer: This post has not been edited by our staff and is published from a syndicated feed. The Original Source of this post can be found at Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest

Under-fire Zidane refuses to give up

Real Madrid coach Zinedine Zidane takes his side to Sevilla this weekend after insisting he has no intention of...

iPhone 12 Review

Of the four members of the new iPhone 12 family, the base iPhone 12 might be easy to overlook. It isn't a radically different...

Opposition leaders demand financial help, GST dues at all-party meet

DMK’s T.R. Baalu, the lone person to raise farmers’ agitation, had his microphone muted. An all-party meeting chaired by Prime Minister Narendra Modi to discuss...

More Articles